Exogenous molecules |
Drugs |
Rifampicin |
Activator and ligand |
Human |
(Blumberg et al., 1998; Li and Chiang, 2005; Li and Chiang, 2006) |
|
RU486 |
Activator |
Human |
(Banerjee et al., 2015; Kliewer, 2015; |
Etomidoline |
Activator |
Human |
Lynch et al., 2021) |
Clotrimazole |
Activator |
Human, weak activatorin rodent |
(Jones et al., 2000; Lehmann et al., 1998; Banerjee et al., 2015; Kliewer, 2015) |
Colfibrate |
Activator and ligand |
Rat |
(Daujat-Chavanieu and Gerbal-Chaloin, 2020) |
Phenobarbital |
Activator |
Human |
(Li et al., 2019; Tamasi et al., 2009) |
Dexamethasone |
Activator |
Human androdent |
(Pascussi et al., 2001; Yueh et al., 2005; Pascussi et al., 2000; Shi et al., 2010) |
Cyclophosphamide (CPA) |
Activator |
Human |
(Lindley et al., 2002; Zhuo et al., 2014) |
Ritanovir |
Activator |
Human |
(Chang and Waxman, 2006; Shehu et al., 2019; Brewer and Chen, 2016) |
Paclitaxel |
Activator |
Human |
(Kostrubsky et al., 1998) |
Felodipine |
Activator |
Human |
(Dybdahl et al., 2012; Pinne et al., 2016) |
Nifedipine |
Activator |
Human |
(Bertilsson et al., 1998; Chang and Waxman, 2006; Lynch et al., 2021) |
Bendipine |
Activator |
Human |
(Bertilsson et al., 1998; Chang and Waxman, 2006; Lynch et al., 2021) |
Carbamazepine |
Activator |
Human |
(El-Sankary et al., 2001; Luo et al., 2002) |
Bosentan |
Activator |
Human |
(van Giersbergen et al., 2002) |
Mevastatin |
Activator |
Human |
(Raucy et al., 2002) |
Tamoxifen |
Activator |
Human |
(Desai et al., 2002; Zhuo et al., 2014) |
Topotecan |
Activator |
Human |
(Schuetz et al., 2002) |
Lacidipine |
Activator |
Human |
(Bertilsson et al., 1998; Chang and Waxman, 2006; Lynch et al., 2021) |
Resveratrol |
Inhibitor |
Human |
(Smutny and Pavek, 2014), (Deng et al., 2014) |
Ketoconazole |
Inhibitor |
Human |
(Mani et al., 2013; Huang et al., 2007) |
Exogenous molecules |
Drugs |
ET-743 |
Inhibitor |
Human |
(Synold et al., 2001) |
|
SPA70 |
Inhibitor |
Human |
(Lin et al., 2017) |
Phytochemicals |
St. John’s wort (hyperforin) |
Activator |
Human |
(Watkins et al., 2003; Kliewer, 2015) |
|
Forskolin |
Activator |
Human, mouse |
(Seamon et al., 1981; Ding and Staudinger, 2005a) |
Guggulsterones |
Activator |
Human, mouse |
(Chang and Waxman, 2006; Brobst et al., 2004; Ding and Staudinger, 2005b) |
Artemisinin |
Activator |
Human |
(Burk et al., 2005) |
Kava extract |
Activator |
Human |
(Raucy, 2003), (Ma et al., 2004) |
Coumestrol |
Repressor |
Human and humanized mouse |
(Wang et al., 2008) |
Sulforaphane |
Repressor |
Human |
(Zhou et al., 2007) |
Schiandrol B (SolB) |
Activator |
Human |
(Zeng et al., 2017) |
Environmental chemicals |
Bisphenol A (BPA) |
Activator |
Human |
(Sui et al., 2012; Barrett, 2012) |
|
PBDEs |
Activator |
Human, rodents |
(Pacyniak et al., 2007; Sueyoshi et al., 2014) |
PCBs |
Activator |
Human, rodents |
(Egusquiza et al., 2020; Wahlang et al., 2014; Jacobs et al., 2005) |
PFOA |
Activator |
Rodents |
(Bjork et al., 2011; Ren et al., 2009) |
PFOS |
Activator |
Human, rodents |
(Bjork et al., 2011; Ren et al., 2009) |
Phthalate monoesters |
Activator |
Human, rodents |
(Hurst and Waxman, 2004; Cooper et al., 2008) |
Metal ions (Pb+, Ag+), As |
Activator |
Zebrafish, humanized mouse |
(Liu et al., 2019; Medina-Diaz et al., 2009) |
Uranium |
Activator |
Rat |
(Souidi et al., 2005) |
Exogenous molecules |
Pesticides |
Chlordane (trans-nonachlor) |
Activator |
Human |
(Jacobs et al., 2005) |
Alachlor |
Activator |
Human, rat |
(Mikamo et al., 2003; Lemaire et al., 2006) |
Nonylphenol |
Activator |
Fish |
(Meucci and Arukwe, 2006) |
Cis-bifenthrin |
Activator |
Human |
(Xiang et al., 2018) |
DDT |
Activator |
Human, mouse |
(Lemaire et al., 2004) |
Dieldrin |
Activator |
Human |
(Milnes et al., 2008) |
Cholpyrifos |
Activator |
Mouse |
(Lemaire et al., 2004) |
Cypermethrine |
Activator |
Human |
(Lemaire et al., 2004; Abass et al., 2012) |
Endosulfan |
Activator |
Human |
(Lemaire et al., 2004; Coumoul et al., 2002) |
|
Dane |
Activator |
Human, rat |
(Lemaire et al., 2004; Mikamo et al., 2003) |
Methoxychlor |
Activator |
Human, rat |
(Lemaire et al., 2004; Mikamo et al., 2003; Lemaire et al., 2006) |
Miscellaneous |
CITCO |
Activator |
Humans |
(Lin et al., 2020) |
SR12813 |
Activator |
Human, rabbit, canine |
(Jones et al., 2000; Pinne et al., 2016) |
Pregnenolone 16Chlorpyrifosile (PCN) |
Activator and ligand |
Rodents |
(Ma et al., 2008; Marek et al., 2005) |
FKK6 |
Activator and ligand |
Human, mouse |
(Dvořák et al., 2020) |
Food components |
Aflatoxin B1 |
Activator |
Human |
(Ayed-Boussema et al., 2012a; Daujat-Chavanieu and Gerbal-Chaloin, 2020) |
Patulin |
Activator |
Human |
(Ayed-Boussema et al., 2012b) |
Isorhamnetin |
Activator and ligand |
Mouse |
(Dou et al., 2014) |
High fat diet |
Activator |
Mouse |
(Saraswathi et al., 2017) |
|
Alpha-ketoglutarate |
Activator |
Pig |
(He et al., 2017) |
|
Ochratoxin A |
Inhibitor |
Human |
(Doricakova and Vrzal, 2015; Daujat-Chavanieu and Gerbal-Chaloin, 2020) |
Vitamins |
Vit K |
Activator and ligand |
Mouse |
(Sultana et al., 2018; Tabb et al., 2003; Avior et al., 2015) |
Vit E |
Activator |
Human |
(Landes et al., 2003) |
Endogenous molecules |
Microbial metabolites |
Lithocholic acid (LCA) |
Activator |
Human, rodents |
(Wistuba et al., 2007; Staudinger et al., 2001) |
3-keto LCA |
Activator |
Human, rodents |
(Xie et al., 2001; Staudinger et al., 2001) |
Deoxycholic acid (DCA) |
Activator |
Mouse |
(Xie et al., 2001) |
Indole-3-propionic acid |
Ligand and activator |
Human, mouse |
(Venkatesh et al., 2014) |
Skatole (3-methyl-indole) |
Partial agonist and low affinity ligand |
Human |
(Vyhlidalova et al., 2020) |
Lipopolysaccharides (LPS) |
Inhibitor |
Mouse |
(Xu et al., 2004; Xu et al., 2005) |